These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 38661816)

  • 1. The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes.
    Jalilova A; Pilan BŞ; Demir G; Özbaran B; Balkı HG; Arslan E; Köse SG; Özen S; Darcan Ş; Gökşen D
    Eur J Pediatr; 2024 Jul; 183(7):3095-3103. PubMed ID: 38661816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Glycemic Outcomes During the MiniMed
    Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose and Psychosocial Outcomes 12 Months Following Transition from Multiple Daily Injections to Advanced Hybrid Closed Loop in Youth with Type 1 Diabetes and Suboptimal Glycemia.
    Michaels VR; Boucsein A; Watson AS; Frewen CM; Sanders OJ; Haszard JJ; Jones SD; Milford-Hughes PJ; de Bock MI; Wheeler BJ
    Diabetes Technol Ther; 2024 Jan; 26(1):40-48. PubMed ID: 37823890
    [No Abstract]   [Full Text] [Related]  

  • 4. Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring.
    van den Heuvel T; Kolassa R; Keuthage W; Kroeger J; Ré R; de Portu S; Vorrink L; Shin J; Castañeda J; Vigersky R; Cohen O
    J Diabetes Sci Technol; 2024 Sep; 18(5):1132-1138. PubMed ID: 36949671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric Study.
    Lablanche S; Delagenière J; Jalbert M; Sonnet E; Benichou M; Arnold N; Spiteri A; Le Berre JP; Renard E; Chevalier N; Borot S; Bonnemaison E; Coffin C; Teissier MP; Benhamou PY; Borel JC; Penfornis A; Joubert M; Kessler L
    Diabetes Technol Ther; 2024 Jun; 26(6):426-432. PubMed ID: 38236643
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems.
    Bahillo-Curieses P; Fernández Velasco P; Pérez-López P; Vidueira Martínez AM; Nieto de la Marca MO; Díaz-Soto G
    Endocrine; 2024 Nov; 86(2):539-545. PubMed ID: 38814372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of advanced hybrid closed loop systems in children with type 1 diabetes younger than 6 years.
    Rapini N; Martino M; Arnaldi C; Deodati A; Anagnostopoulou L; Amodeo ME; Ciampalini P; Pampanini V; Lorubbio A; Tosini D; Cianfarani S; Schiaffini R
    Front Endocrinol (Lausanne); 2024; 15():1382920. PubMed ID: 38836230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI).
    Petrovski G; Al Khalaf F; Campbell J; Day E; Almajaly D; Hussain K; Pasha M; Umer F; Hamdan M; Khalifa A
    BMC Endocr Disord; 2022 Mar; 22(1):80. PubMed ID: 35351095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single-centre real-world study.
    Eviz E; Killi NE; Karakus KE; Can E; Gokce T; Yesiltepe Mutlu G; Hatun S
    Diabet Med; 2024 Aug; 41(8):e15333. PubMed ID: 38671595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time In Tight Range in children and adolescents with type 1 diabetes: A cross-sectional observational single centre study evaluating efficacy of new advanced technologies.
    Schiaffini R; Lumaca A; Martino M; Rapini N; Deodati A; Amodeo ME; Ciampalini P; Matteoli MC; Pampanini V; Cianfarani S
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3826. PubMed ID: 38824455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.
    Benhalima K; Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C
    Lancet Diabetes Endocrinol; 2024 Jun; 12(6):390-403. PubMed ID: 38697182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study.
    Seget S; Jarosz-Chobot P; Ochab A; Polanska J; Rusak E; Witoszek P; Chobot A
    Front Endocrinol (Lausanne); 2022; 13():1036808. PubMed ID: 36303875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study group.
    Landau Z; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Jacobi-Polishook T; Ben Ari T; Abiri S; Haim A; Nir J; Rachmiel M; Pinhas-Hamiel O
    Endocrine; 2024 Jun; 84(3):943-950. PubMed ID: 38225516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study.
    Bassi M; Franzone D; Dufour F; Spacco G; Cresta F; d'Annunzio G; Tantari G; Calevo MG; Castellani C; Minuto N; Casciaro R
    Front Endocrinol (Lausanne); 2024; 15():1347141. PubMed ID: 38966218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment.
    Rizzi A; Tartaglione L; Lucaccini Paoli L; Leo ML; Popolla V; Viti L; Barberio A; Di Leo M; Pontecorvi A; Pitocco D
    Diabetes Obes Metab; 2024 Sep; 26(9):4078-4086. PubMed ID: 39010292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes.
    Piccini B; Pessina B; Casalini E; Lenzi L; Toni S
    Pediatr Diabetes; 2022 Dec; 23(8):1647-1655. PubMed ID: 36317539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Open-Label, Single-Arm, Single-Center Follow-Up Study of the Application of the Advanced Hybrid Closed Loop System in Well-Controlled Children and Adolescents with Type 1 Diabetes.
    Seget S; Rusak E; Polanska J; Jarosz-Chobot P
    Diabetes Technol Ther; 2022 Nov; 24(11):824-831. PubMed ID: 35852811
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.
    Wheeler BJ; Collyns OJ; Meier RA; Betts ZL; Frampton C; Frewen CM; Galland B; Hewapathirana NM; Jones SD; Chan DSH; Roy A; Grosman B; Kurtz N; Shin J; Vigersky RA; de Bock MI
    Acta Diabetol; 2022 Jan; 59(1):31-37. PubMed ID: 34453208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Effectiveness of an Advanced Hybrid Closed-Loop System in a Cohort of Children and Adolescents With Type 1 Diabetes: A 1-Year Real-World Study.
    Passanisi S; Salzano G; Bombaci B; Minuto N; Bassi M; Bonfanti R; Scialabba F; Mozzillo E; Di Candia F; Monti S; Graziani V; Maffeis C; Piona CA; Arnaldi C; Tosini D; Felappi B; Roppolo R; Zanfardino A; Delvecchio M; Lo Presti D; Calzi E; Ripoli C; Franceschi R; Reinstadler P; Rabbone I; Maltoni G; Alibrandi A; Zucchini S; Marigliano M; Lombardo F;
    Diabetes Care; 2024 Jun; 47(6):1084-1091. PubMed ID: 38626260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes.
    Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A; Gil-Poch E; Martín-Romo I; Arroyo-Díez FJ
    Diabetes Technol Ther; 2021 Sep; 23(9):609-615. PubMed ID: 33784187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.